186 related articles for article (PubMed ID: 6325430)
41. Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation.
Bremer EG; Hakomori S; Bowen-Pope DF; Raines E; Ross R
J Biol Chem; 1984 Jun; 259(11):6818-25. PubMed ID: 6327695
[TBL] [Abstract][Full Text] [Related]
42. Platelet-derived growth factor. Specific binding to target cells.
Huang JS; Huang SS; Kennedy B; Deuel TF
J Biol Chem; 1982 Jul; 257(14):8130-6. PubMed ID: 6282873
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of platelet-derived growth factor-BB-induced fibroblast proliferation by plasmin-activated alpha 2-macroglobulin is mediated via an alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein-dependent mechanism.
Bonner JC; Badgett A; Hoffman M; Lindroos PM
J Biol Chem; 1995 Mar; 270(11):6389-95. PubMed ID: 7534312
[TBL] [Abstract][Full Text] [Related]
44. Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents.
Bowen-Pope DF; Vogel A; Ross R
Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2396-400. PubMed ID: 6326125
[TBL] [Abstract][Full Text] [Related]
45. Differential binding and regulation of platelet-derived growth factor A and B chain isoforms by alpha 2-macroglobulin.
Bonner JC; Osornio-Vargas AR
J Biol Chem; 1995 Jul; 270(27):16236-42. PubMed ID: 7541796
[TBL] [Abstract][Full Text] [Related]
46. Neomycin is a platelet-derived growth factor (PDGF) antagonist that allows discrimination of PDGF alpha- and beta-receptor signals in cells expressing both receptor types.
Vassbotn FS; Ostman A; Siegbahn A; Holmsen H; Heldin CH
J Biol Chem; 1992 Aug; 267(22):15635-41. PubMed ID: 1322402
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of PDGF receptor binding and PDGF-stimulated biological activity in vitro and of intimal lesion formation in vivo by 2-bromomethyl-5-chlorobenzene sulfonylphthalimide.
Mullins DE; Hamud F; Reim R; Davis HR
Arterioscler Thromb; 1994 Jul; 14(7):1047-55. PubMed ID: 8018659
[TBL] [Abstract][Full Text] [Related]
48. Increase of (Ca2+ +Mg2+)-ATPase activity of renal basolateral membranes by platelet-derived growth factor through a specific receptor.
Itoh K; Morimoto S; Shiraishi T; Taniguchi K; Onishi T; Kumahara Y
Biochem Biophys Res Commun; 1988 Jun; 153(3):1315-23. PubMed ID: 2839172
[TBL] [Abstract][Full Text] [Related]
49. PDGF-stimulated fibroblast proliferation is enhanced synergistically by receptor-recognized alpha 2-macroglobulin.
Bonner JC; Badgett A; Osornio-Vargas AR; Hoffman M; Brody AR
J Cell Physiol; 1990 Oct; 145(1):1-8. PubMed ID: 1698792
[TBL] [Abstract][Full Text] [Related]
50. Receptors for epidermal growth factor in the rat uterus.
Mukku VR; Stancel GM
Endocrinology; 1985 Jul; 117(1):149-54. PubMed ID: 2988913
[TBL] [Abstract][Full Text] [Related]
51. Cultured Kaposi's sarcoma-derived cells express functional PDGF A-type and B-type receptors.
Werner S; Hofschneider PH; Heldin CH; Ostman A; Roth WK
Exp Cell Res; 1990 Mar; 187(1):98-103. PubMed ID: 2153568
[TBL] [Abstract][Full Text] [Related]
52. Use of the heterobifunctional cross-linker m-maleimidobenzoyl N-hydroxysuccinimide ester to affinity label cholecystokinin binding proteins on rat pancreatic plasma membranes.
Madison LD; Rosenzweig SA; Jamieson JD
J Biol Chem; 1984 Dec; 259(23):14818-23. PubMed ID: 6094576
[TBL] [Abstract][Full Text] [Related]
53. Reconstitution of the high affinity epidermal growth factor receptor on cell-free membranes after transmodulation by platelet-derived growth factor.
Walker F; Burgess AW
J Biol Chem; 1991 Feb; 266(5):2746-52. PubMed ID: 1993654
[TBL] [Abstract][Full Text] [Related]
54. Isoform-specific regulation of platelet-derived growth factor activity and binding in osteoblast-enriched cultures from fetal rat bone.
Centrella M; McCarthy TL; Kusmik WF; Canalis E
J Clin Invest; 1992 Apr; 89(4):1076-84. PubMed ID: 1313443
[TBL] [Abstract][Full Text] [Related]
55. A comparison of binding properties and structure of NGF receptor on PC12 pheochromocytoma and A875 melanoma cells.
Buxser SE; Watson L; Johnson GL
J Cell Biochem; 1983; 22(4):219-33. PubMed ID: 6323498
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of epidermal growth factor binding to Swiss 3T3 cells by human platelet release-products.
Brown KD; Blakeley DM; MacDonald M
Biosci Rep; 1983 Jul; 3(7):659-66. PubMed ID: 6313091
[TBL] [Abstract][Full Text] [Related]
57. Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation.
Keating MT; Escobedo JA; Williams LT
J Biol Chem; 1988 Sep; 263(26):12805-8. PubMed ID: 2843499
[TBL] [Abstract][Full Text] [Related]
58. Evidence for the platelet-derived growth factor-stimulated tyrosine phosphorylation of the platelet-derived growth factor receptor in vivo. Immunopurification using a monoclonal antibody to phosphotyrosine.
Frackelton AR; Tremble PM; Williams LT
J Biol Chem; 1984 Jun; 259(12):7909-15. PubMed ID: 6203898
[TBL] [Abstract][Full Text] [Related]
59. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors.
Raines EW; Lane TF; Iruela-Arispe ML; Ross R; Sage EH
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1281-5. PubMed ID: 1311092
[TBL] [Abstract][Full Text] [Related]
60. Biosynthetic and glycosylation studies of cell surface platelet-derived growth factor receptors.
Daniel TO; Milfay DF; Escobedo J; Williams LT
J Biol Chem; 1987 Jul; 262(20):9778-84. PubMed ID: 3036871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
